ATGC-B

Archives for Transforming Genomics of Cancers, Bangladesh (ATGC-B)

2nd TCGA CONFERENCE AND WORKSHOP IN INDIA

(Virtual Edition)

Venue:

Online

Date:

December 3-5, 2020

Archives for Transforming Genomics of Cancers, Bangladesh (ATGC-B) is a landmark initiative taken by EuGEF Research Group with the aim of cataloging major cancer-causing genome alterations through large-scale genome sequencing and integrated multi-dimensional analyses in Bangladesh taking The Cancer Genome Atlas Program - National Cancer Institute as the gold standard

REGISTRAION

EuGEF is actively participating in the successful organization of

ABOUT TCGA

The Cancer Genome Atlas (TCGA), a landmark cancer genomics program, molecularly characterized over 20,000 primary cancer and matched normal samples spanning 33 cancer types. This joint effort between the National Cancer Institute and the National Human Genome Research Institute began in 2006, bringing together researchers from diverse disciplines and multiple institutions. After 12 years, contributions from over 11,000 patients, and incredible effort from thousands of researchers, TCGA has produced a rich data set of immeasurable value. This data remains available to the public as a trusted reference that will be mined for many years.

WHY TCGA-RELATED TRAINING?

TCGA project has had tremendous impact on boosting translational cancer research in the west. In the past few years, many multi-disciplinary scientists in India have embarked on data-mining driven cancer research. It is a general observation that this ever-growing cancer research community has now increasingly started exploring TCGA for their research needs. However, a systematic exploration of the full resources and potential of TCGA has not been made available to the Indian cancer research or data science professionals.

In parallel, Indian scientific agencies have begun to envisage the creation of TCGA-like resources for Indian population (for e.g. The Indian Cancer Genome Database, GenomeIndia project etc). These projects are expected to accelerate the pace of cancer research in India in the coming years. Therefore, this is an opportune time to conduct an intensive training workshop in India, perhaps, in collaboration with TCGA.

The proposed activity is well-aligned to the CTCR agenda of capacity building of the Indian cancer research community. This workshop co-organised with TCGA is expected to provide the ideal foundation for long-term tie-ups between Indian cancer researchers and TCGA teams.